111 related articles for article (PubMed ID: 30633389)
1. Cancer metabolism in a snapshot: MRS(I).
Julià-Sapé M; Candiota AP; Arús C
NMR Biomed; 2019 Oct; 32(10):e4054. PubMed ID: 30633389
[TBL] [Abstract][Full Text] [Related]
2. Monitoring Early Changes in Tumor Metabolism in Response to Therapy Using Hyperpolarized
Lim H; Martínez-Santiesteban F; Jensen MD; Chen A; Wong E; Scholl TJ
Tomography; 2020 Sep; 6(3):290-300. PubMed ID: 32879899
[TBL] [Abstract][Full Text] [Related]
3. HDAC inhibition in glioblastoma monitored by hyperpolarized
Radoul M; Najac C; Viswanath P; Mukherjee J; Kelly M; Gillespie AM; Chaumeil MM; Eriksson P; Delos Santos R; Pieper RO; Ronen SM
NMR Biomed; 2019 Feb; 32(2):e4044. PubMed ID: 30561869
[TBL] [Abstract][Full Text] [Related]
4. Correlations between magnetic resonance spectroscopy and image-guided histopathology, with special attention to radiation necrosis.
Rock JP; Hearshen D; Scarpace L; Croteau D; Gutierrez J; Fisher JL; Rosenblum ML; Mikkelsen T
Neurosurgery; 2002 Oct; 51(4):912-9; discussion 919-20. PubMed ID: 12234397
[TBL] [Abstract][Full Text] [Related]
5. Imaging tumour cell metabolism using hyperpolarized 13C magnetic resonance spectroscopy.
Witney TH; Brindle KM
Biochem Soc Trans; 2010 Oct; 38(5):1220-4. PubMed ID: 20863288
[TBL] [Abstract][Full Text] [Related]
6. Combined hyperpolarized
Hansen AE; Gutte H; Holst P; Johannesen HH; Rahbek S; Clemmensen AE; Larsen MME; Schøier C; Ardenkjaer-Larsen J; Klausen TL; Kristensen AT; Kjaer A
Eur J Radiol; 2018 Jun; 103():6-12. PubMed ID: 29803387
[TBL] [Abstract][Full Text] [Related]
7. The Role of Lactate Metabolism in Prostate Cancer Progression and Metastases Revealed by Dual-Agent Hyperpolarized
Bok R; Lee J; Sriram R; Keshari K; Sukumar S; Daneshmandi S; Korenchan DE; Flavell RR; Vigneron DB; Kurhanewicz J; Seth P
Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30813322
[TBL] [Abstract][Full Text] [Related]
8. MRS and MRSI guidance in molecular medicine: targeting and monitoring of choline and glucose metabolism in cancer.
Glunde K; Jiang L; Moestue SA; Gribbestad IS
NMR Biomed; 2011 Jul; 24(6):673-90. PubMed ID: 21793073
[TBL] [Abstract][Full Text] [Related]
9. Hyperpolarized C-13 spectroscopic imaging of the TRAMP mouse at 3T-initial experience.
Chen AP; Albers MJ; Cunningham CH; Kohler SJ; Yen YF; Hurd RE; Tropp J; Bok R; Pauly JM; Nelson SJ; Kurhanewicz J; Vigneron DB
Magn Reson Med; 2007 Dec; 58(6):1099-106. PubMed ID: 17969006
[TBL] [Abstract][Full Text] [Related]
10. Comparison of reproducibility of single voxel spectroscopy and whole-brain magnetic resonance spectroscopy imaging at 3T.
Zhang Y; Taub E; Salibi N; Uswatte G; Maudsley AA; Sheriff S; Womble B; Mark VW; Knight DC
NMR Biomed; 2018 Apr; 31(4):e3898. PubMed ID: 29436038
[TBL] [Abstract][Full Text] [Related]
11. Molecular imaging coupled to pattern recognition distinguishes response to temozolomide in preclinical glioblastoma.
Delgado-Goñi T; Julià-Sapé M; Candiota AP; Pumarola M; Arús C
NMR Biomed; 2014 Nov; 27(11):1333-45. PubMed ID: 25208348
[TBL] [Abstract][Full Text] [Related]
12. MR Molecular Imaging of Brain Cancer Metabolism Using Hyperpolarized 13C Magnetic Resonance Spectroscopy.
Najac C; Ronen SM
Top Magn Reson Imaging; 2016 Oct; 25(5):187-196. PubMed ID: 27748711
[TBL] [Abstract][Full Text] [Related]
13. Multimodal assessment of in vivo metabolism with hyperpolarized [1-13C]MR spectroscopy and 18F-FDG PET imaging in hepatocellular carcinoma tumor-bearing rats.
Menzel MI; Farrell EV; Janich MA; Khegai O; Wiesinger F; Nekolla S; Otto AM; Haase A; Schulte RF; Schwaiger M
J Nucl Med; 2013 Jul; 54(7):1113-9. PubMed ID: 23596002
[TBL] [Abstract][Full Text] [Related]
14. In vivo ³¹P magnetic resonance spectroscopic imaging (MRSI) for metabolic profiling of human breast cancer xenografts.
Esmaeili M; Moestue SA; Hamans BC; Veltien A; Kristian A; Engebråten O; Maelandsmo GM; Gribbestad IS; Bathen TF; Heerschap A
J Magn Reson Imaging; 2015 Mar; 41(3):601-9. PubMed ID: 24532410
[TBL] [Abstract][Full Text] [Related]
15. In vivo Metabolic Profiles as Determined by
Wenger KJ; Hattingen E; Franz K; Steinbach J; Bähr O; Pilatus U
Clin Neuroradiol; 2019 Mar; 29(1):27-36. PubMed ID: 28983683
[TBL] [Abstract][Full Text] [Related]
16. Hyperpolarized (13)C-lactate to (13)C-bicarbonate ratio as a biomarker for monitoring the acute response of anti-vascular endothelial growth factor (anti-VEGF) treatment.
Park JM; Spielman DM; Josan S; Jang T; Merchant M; Hurd RE; Mayer D; Recht LD
NMR Biomed; 2016 May; 29(5):650-9. PubMed ID: 26990457
[TBL] [Abstract][Full Text] [Related]
17. Proton MR spectroscopy of the prostate.
Mueller-Lisse UG; Scherr MK
Eur J Radiol; 2007 Sep; 63(3):351-60. PubMed ID: 17709223
[TBL] [Abstract][Full Text] [Related]
18. Monitoring the effects of BCNU chemotherapy Wafers (Gliadel) in glioblastoma multiforme with proton magnetic resonance spectroscopic imaging at 3.0 Tesla.
Dyke JP; Sanelli PC; Voss HU; Serventi JV; Stieg PE; Schwartz TH; Ballon D; Shungu DC; Pannullo SC
J Neurooncol; 2007 Mar; 82(1):103-10. PubMed ID: 17031552
[TBL] [Abstract][Full Text] [Related]
19. Hyperpolarized carbon-13 magnetic resonance spectroscopic imaging: a clinical tool for studying tumour metabolism.
Zaccagna F; Grist JT; Deen SS; Woitek R; Lechermann LM; McLean MA; Basu B; Gallagher FA
Br J Radiol; 2018 May; 91(1085):20170688. PubMed ID: 29293376
[TBL] [Abstract][Full Text] [Related]
20. [1H magnetic resonance spectroscopy of the prostate].
Mueller-Lisse UG; Scherr M
Radiologe; 2003 Jun; 43(6):481-8. PubMed ID: 12827263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
